Dendreon Corporation Stock Nasdaq
Equities
US24823Q1076
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2015 | Endo : Drugmaker Valeant close to buying Salix - source | RE |
2015 | Dendreon : Valeant secures financing for potential Salix bid: Bloomberg | RE |
1st Jan change | Capi. | |
---|---|---|
-1.42% | 41.52B | |
+42.15% | 39.9B | |
+1.97% | 38.83B | |
-14.19% | 26.05B | |
+1.82% | 23.78B | |
-24.55% | 18.26B | |
-4.07% | 11.65B | |
+21.36% | 11.53B | |
+8.20% | 11.2B |
- Stock Market
- Equities
- Stock
- Stock